Sigma Healthcare Shares Jump After Exiting Boots Acquisition Process 
BOJ Raises Interest Rates to 31-Year High, Signals Strong Focus on Inflation Risks 
Oil Prices Tumble as U.S.-Iran Peace Deal Eases Supply Concerns 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
SpaceX Stock Gets $175 Target as Analysts See Massive Growth Ahead 
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision 
RBA Expected to Hold Interest Rates at 4.35% as Markets Watch AUD/USD and ASX 200 
Elon Musk Becomes World's First Trillionaire After SpaceX IPO Surge 
Gold Prices Surge Above $4,300 as US-Iran Peace Deal Weakens Dollar and Oil 
Taiwan Central Bank Likely to Keep Interest Rates Unchanged Through 2027 
U.S. Gasoline Prices Fall Below $4 as U.S.-Iran Deal Eases Oil Market Concerns 
Wall Street Surges as US-Iran Deal Eases Oil Price and Inflation Concerns 
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms 
Global Motor Oil and Auto Paint Shortages Persist Despite Potential U.S.-Iran Peace Deal 
China Industrial Output Beats Forecasts as Domestic Demand Weakens 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push 
Royal Philips NV, a Dutch multinational corporation, revealed this week that it would be laying off thousands of employees worldwide. The company said it was forced to do so due to the plunging sales and other issues.
Philips said it would cut five percent of its workforce, and this is equivalent to about 4,000 people. The company's chief explained that this move is part of a scheme to combat the falling sales, which were partly due to the recall of its sleep apnea machine and eventually taking a massive hit from this - amounting to €1.3 billion.
The job cuts were revealed by Roy Jakobs, Philips' current chief executive officer, during the recent performance report for the third quarter of 2022. He confirmed that they had faced many challenges, and the Q3 report shows this.
Fox Business reported that the firm has 80,000 employees, and eliminating a small percentage is needed for the company to survive and for Philips to achieve its growth potential. It was noted that the firm incurred huge losses after recalling its Respironics Ventilators and other machines due to health risks.
These devices were sold around the world, and millions of units were already distributed, so the impact on the company was great. With this, Philips is expecting to see a mid to single-digit comparable sales decline in the last quarter of this year. As per Reuters, the job cuts may be worldwide but will mostly affect workers in the United States and the Netherlands.
"My immediate priority is to improve execution so that we can start rebuilding the trust of patients, consumers and customers, as well as shareholders and our other stakeholders," Royal Philips CEO, Roy Jakobs, said in a press release.
He further explained, "We will do this by first further strengthening our patient safety and quality management and addressing the various facets of the Philips Respironics recall by urgently improving our supply chain operations and simplifying our way of working to improve productivity and increase agility and this includes the difficult, but necessary decision to immediately reduce our workforce by around 4,000 roles globally."
